NTRR: Deadly Outbreaks Make Anti-Microbial Solutions a Necessity in 2014
With dangerous, antibiotic-resistant staph infections on the rise, wellness innovator Neutra Corp. (OTCBB: NTRR) has made the delivery of cutting-edge anti-microbial solutions to the epidemic a top priority for the new year.
According to a recent examination by USA Today, the infection rate of MRSA, the sometimes-deadly, drug-resistant bacteria that has notoriously attacked hospitals and even NFL locker rooms, is far more common than government statistics suggest. MRSA staph infections sicken hundreds of thousands of people in America alone each year, causing symptoms from skin boils to pneumonia. The disease claims upwards of 20,000 lives annually.
Institutions such as hospitals, schools, and sports leagues are particularly at risk from the difficult-to-combat disease. To help eliminate the threat, NTRR is working fast to bring new, effective products to market capable of sanitizing the locations favored by the MRSA bacteria.
NTRR’s joint venture partner, Surface to Air Solutions (S2O2), has acquired a Texas-based firm that’s developed a potentially lucrative anti-microbial coating capable of adhering to sporting equipment and facilities, preventing viral and bacterial contamination. In addition to preventing the spread of staph from the locker room to the waiting room, it’s also an effective defense against common diseases and illnesses from the flu to H1N1.
“Delivering this incredible new product to the institutions that need it most will be a major focus for the company in 2014,” said NTRR CEO Sydney Jim.
Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing wellness sector alongside Herbalife Ltd. (NYSE: HLF), Vitamin Shoppe (NYSE: VSI), Nutraceutical International Corp. (NASDAQ: NUTR) and Schiff Nutrition International Inc. (NYSE: WNI).
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
With dangerous, antibiotic-resistant staph infections on the rise, wellness innovator Neutra Corp. (OTCBB: NTRR) has made the delivery of cutting-edge anti-microbial solutions to the epidemic a top priority for the new year.
According to a recent examination by USA Today, the infection rate of MRSA, the sometimes-deadly, drug-resistant bacteria that has notoriously attacked hospitals and even NFL locker rooms, is far more common than government statistics suggest. MRSA staph infections sicken hundreds of thousands of people in America alone each year, causing symptoms from skin boils to pneumonia. The disease claims upwards of 20,000 lives annually.
Institutions such as hospitals, schools, and sports leagues are particularly at risk from the difficult-to-combat disease. To help eliminate the threat, NTRR is working fast to bring new, effective products to market capable of sanitizing the locations favored by the MRSA bacteria.
NTRR’s joint venture partner, Surface to Air Solutions (S2O2), has acquired a Texas-based firm that’s developed a potentially lucrative anti-microbial coating capable of adhering to sporting equipment and facilities, preventing viral and bacterial contamination. In addition to preventing the spread of staph from the locker room to the waiting room, it’s also an effective defense against common diseases and illnesses from the flu to H1N1.
“Delivering this incredible new product to the institutions that need it most will be a major focus for the company in 2014,” said NTRR CEO Sydney Jim.
Neutra Corp. is dedicated to commercializing innovative, all-natural products to compete in the fast-growing wellness sector alongside Herbalife Ltd. (NYSE: HLF), Vitamin Shoppe (NYSE: VSI), Nutraceutical International Corp. (NASDAQ: NUTR) and Schiff Nutrition International Inc. (NYSE: WNI).
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products and services as well as protective, anti-microbial coatings for indoor and outdoor surfaces. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Neutra Corp.
Sydney Jim, 813-367-2041
President and CEO
info@neutracorp.com
